A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutions

Pharmacotherapy

Volumn 17, Issue 2, 1997, Pages 277-281

  Bailey, Thomas C ^a   Ritchie, David J ^b,c   McMullin, S Troy ^c   Kahn, Michael ^a,d   Reichley, Richard M ^c   Casabar, Ed ^c   Shannon, William ^a   Dunagan, William Claiborne ^a,d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST LOUIS COLLEGE OF PHARMACY   (United States)

^c BARNES JEWISH HOSPITAL   (United States)

^d BJC HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; HEALTH PROGRAM; HOSPITAL MANAGEMENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; TEACHING HOSPITAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; ANTI-BACTERIAL AGENTS; COMMUNICABLE DISEASES; COSTS AND COST ANALYSIS; DRUG COSTS; FEMALE; HOSPITALS, TEACHING; HUMANS; INJECTIONS, INTRAVENOUS; LENGTH OF STAY; MALE; MIDDLE AGED; MISSOURI; PHARMACISTS; PROSPECTIVE STUDIES;

EID: 0030894720     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Quintiliani R, Cooper BW, Briceland LL, Nightingale CH. Economic impact of streamlining antibiotic administration. Am J Med 1987;82(suppl 4A):391-4.
2. Briceland LL, Nightingale CH, Quintiliani R, et al. Antibiotic streamlining from combination therapy to monotherapy using an interdisciplinary approach. Arch Intern Med 1988;148: 2019-22.
3. Ehrenkranz NJ, Nerenberg DE, Shultz JM, Slater KC. Intervention to discontinue parenteral antimicrobial therapy in patients hospitalized with pulmonary infections: effect on shortening patient stay. Infect Control Hosp Epidemiol 1992;13:21-32.
4. Pastel DA, Chang S, Nessim S, et al. Department of pharmacy-initiated program for streamlining empirical antibiotic therapy. Hosp Pharm 1992;27:596-603, 614.
5. Frighetto L, Nickoloff D, Martinusen SM, et al. Intravenous-to-oral stepdown program: four years of experience in a large teaching hospital. Ann Pharmacother 1992;26:1447-51.
6. Ehrenkranz NJ, Nerenberg DE, Slater KC, Shultz JM. Intervention to discontinue parenteral antimicrobial therapy in hospitalized patients with urinary tract infection, skin and soft tissue infection, or no evident infection. Infect Control Hosp Epidemiol 1993;14:517-22.
7. Weingarten SR, Riedinger MS, Varis G, et al. Identification of low-risk hospitalized patients with pneumonia. Implications for early conversion to oral antimicrobial therapy. Chest 1994;105:1109-15.
8. Iezzoni LI, Ash AS, Shwartz M, et al. Predicting who dies depends on how severity is measured: implications for evaluating patient outcomes. Ann Intern Med 1995;123: 763-70.
9. Dunagan WC, Medoff G. Formulary control of antimicrobial usage. What price freedom? Diagn Microbiol Infect Dis 1993;16:265-74.
10. Manton KG, Woodbury MA, Vertrees JC, Stallard E. Use of Medicare services before and after introduction of the prospective payment system. Health Services Res 1993; 28(3):269-92.
11. Paladino JA, Sperry HE, Backes JM, et al. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics. Am J Med 1991;91:462-70.
12. Grasela TH, Paladino JA, Schentag JJ, et al. Clinical and economic impact of oral ciprofloxacin as follow-up to parenteral antibiotics. Ann Pharmacother 1991;25:857-62.
13. Hunter KA, Dormaier GK. Pharmacist-managed intravenous to oral step-down program. Clin Ther 1995;17:534-40.